Cargando…

HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma

HMG-box transcription factor 1 (HBP1) has been reported to be a tumor suppressor in diverse malignant carcinomas. However, our findings provide a conclusion that HBP1 plays a novel role in facilitating nasopharyngeal carcinoma (NPC) growth. The Kaplan–Meier analysis indicates that high expression HB...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Shiwei, Yang, Sheng, Niu, Man, Zhong, Yancheng, Dan Gao, Zhang, Yanru, Ma, Haotian, Xiong, Wei, Zhou, Ming, Zhou, Yanhong, Xiang, Bo, Li, Guiyuan, Shuai, Cijun, Peng, Shuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833394/ https://www.ncbi.nlm.nih.gov/pubmed/29367693 http://dx.doi.org/10.1038/s41419-017-0175-4

Ejemplares similares

CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity
por: Bonelli, Patrizia, et al.
Publicado: (2014)

An Overview of Long Noncoding RNAs Involved in Bone Regeneration from Mesenchymal Stem Cells
por: Peng, Shuping, et al.
Publicado: (2018)

LncRNA ODIR1 inhibits osteogenic differentiation of hUC-MSCs through the FBXO25/H2BK120ub/H3K4me3/OSX axis
por: He, Shiwei, et al.
Publicado: (2019)

Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy
por: Wei, Pingpin, et al.
Publicado: (2014)

Chemical inhibitors of cyclin-dependent kinase (CDKi) improve pancreatic endocrine differentiation of iPS cells
por: Ning, Heming, et al.
Publicado: (2023)

Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer
por: Zhong, Yancheng, et al.
Publicado: (2016)

The interaction of Lin28A/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer
por: Zhong, Yancheng, et al.
Publicado: (2018)

HMG-boxes, ribosomopathies and neurodegenerative disease
por: Moss, Tom, et al.
Publicado: (2023)

Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice
por: Gagliano, Ambrogio, et al.
Publicado: (2021)

Lin28A Regulates Stem-like Properties of Ovarian Cancer Cells by Enriching RAN and HSBP1 mRNA and Up-regulating its Protein Expression
por: Zhong, Yancheng, et al.
Publicado: (2020)

Break CDK2/Cyclin E1 Interface Allosterically with Small Peptides
por: Chen, Hao, et al.
Publicado: (2014)

Proteasome inhibitors decrease paclitaxel-induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1
por: Hu, Ling, et al.
Publicado: (2021)

The High Mobility Group (Hmg) Boxes of the Nuclear Protein Hmg1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells
por: Degryse, Bernard, et al.
Publicado: (2001)

Nuclear Import of Cdk/Cyclin Complexes: Identification of Distinct Mechanisms for Import of Cdk2/Cyclin E and Cdc2/Cyclin B1
por: Moore, Jonathan D., et al.
Publicado: (1999)

Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73
por: Lam, Frankie, et al.
Publicado: (2014)

MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma
por: Niu, Man, et al.
Publicado: (2016)

The APC/C recruits cyclin B1–Cdk1–Cks in prometaphase before D box recognition to control mitotic exit
por: van Zon, Wouter, et al.
Publicado: (2010)

TOX defines a conserved subfamily of HMG-box proteins
por: O'Flaherty, Emmett, et al.
Publicado: (2003)

LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways
por: Yang, Yixin, et al.
Publicado: (2013)

HMG-box domain stimulation of RAG1/2 cleavage activity is metal ion dependent
por: Kriatchko, Aleksei N, et al.
Publicado: (2008)

Cyclin K goes with Cdk12 and Cdk13
por: Kohoutek, Jiri, et al.
Publicado: (2012)

Molecular docking analysis of piperine with CDK2,CDK4,Cyclin D and Cyclin T proteins
por: Rekha, Umapathy Vidhya, et al.
Publicado: (2020)

Phosphonic Acid Coupling Agent Modification of HAP Nanoparticles: Interfacial Effects in PLLA/HAP Bone Scaffold
por: Shuai, Cijun, et al.
Publicado: (2020)

Cyclin B/CDK1 and Cyclin A/CDK2 phosphorylate DENR to promote mitotic protein translation and faithful cell division
por: Clemm von Hohenberg, Katharina, et al.
Publicado: (2022)

Correction: LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways
por: Yang, Yixin, et al.
Publicado: (2013)

Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
por: Matsumoto, M, et al.
Publicado: (1999)

Phosphorylation of AIB1 at Mitosis Is Regulated by CDK1/CYCLIN B
por: Ferrero, Macarena, et al.
Publicado: (2011)

RNA binding domain of HDV antigen is homologous to the HMG box of SRY
por: Veretnik, S., et al.
Publicado: (2014)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

CDKI-73 Is a Novel Pharmacological Inhibitor of Rab11 Cargo Delivery and Innate Immune Secretion
por: Sorvina, Alexandra, et al.
Publicado: (2020)

Liquid Biopsy: A New Tool for Overcoming CDKi Resistance Mechanisms in Luminal Metastatic Breast Cancer
por: González-Conde, Miriam, et al.
Publicado: (2021)

Linc02349 promotes osteogenesis of human umbilical cord‐derived stem cells by acting as a competing endogenous RNA for miR‐25‐3p and miR‐33b‐5p
por: Cao, Lihua, et al.
Publicado: (2020)

Alterations of cell cycle control proteins SHP-1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells
por: PENG, GANG, et al.
Publicado: (2014)

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
por: Sofi, Shazia, et al.
Publicado: (2022)

Cyclin E1-CDK 2, a potential anticancer target
por: Fang, Dongdong, et al.
Publicado: (2016)

Structural basis for CDK7 activation by MAT1 and Cyclin H
por: Peissert, Stefan, et al.
Publicado: (2020)

High affinity binding of proteins HMG1 and HMG2 to semicatenated DNA loops
por: Gaillard, Claire, et al.
Publicado: (2000)

The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress
por: Joaquin, Manel, et al.
Publicado: (2012)

Are Point Mutations in HMG-CoA Reductases (Hmg1 and Hmg2) a Step towards Azole Resistance in Aspergillus fumigatus?
por: Gonzalez-Jimenez, Irene, et al.
Publicado: (2021)

Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2
por: Zhang, Wengang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t7jli6f27d8q5jc7gqj6tk7q5e